Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |